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ABSTRACT
THE EFFECTS OF MAXIMAL STRENGTH TRAINING ON GAIT AND BALANCE IN
PERSONS WITH MULITPLE SCLEROSIS
By
Janet Klein,
David Park,
Charles Wright,
Michael Zervas

Advisor: Professor Herb Karpatkin
Background: Physical Therapy strength training programs utilizing mild to moderate intensity
are commonly prescribed to address many of the deficits found in multiple sclerosis, but studies
examining the effectiveness of higher intensity strength training in gait and balance have not
been performed. Maximal strength training (MST), which involves lifting nearly maximal
weights (85-95% of an individual’s one repetition maximum [1RM]) with low repetitions, has
been shown to improve functional abilities in both healthy and non-MS impaired populations.
The higher intensity training used in MST may result in greater activation of the CNS, providing
a greater stimulus to improvement than lower intensity training. However, due to concerns
regarding fatigue, clinicians have avoided using maximal loads for resistance training. To date
there are no studies that have examined the effects of MST on functional measures in PwMS.
Purpose: The purpose of this study was to examine the effects of MST on gait and balance in
PwMS and assess whether MST could be tolerated by this population. We hypothesized that
MST would result in improved gait and balance measurements in MS patients, and offer
clinicians another tool with which to improve function in this population.
Subjects: Subjects with a definitive diagnosis of MS were recruited from a MS specialty
practice. Inclusionary criteria required the ability to ambulate for 6 minutes, with or without an
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assistive device. Exclusionary criteria included any type of orthopedic or cardiopulmonary
condition restricting the ability to walk for 6 minutes, and any exacerbations, either immediately
prior (2 weeks or less) or during the study.
Methodology: A pretest/posttest design was used. Baseline measures included subjects’ Berg
Balance Scale (BBS), 6-minute walk test (6MWT), followed by their 1RM lift for each leg using
a leg-press machine. Fatigue Severity Scale (FSS) and the MSIS-29 were also collected during
the initial session. Subjects completed an 8 week protocol consisting of 2 sessions per week,
performing 4 sets of 4 repetitions using the leg-press for each leg at 85-95% of their 1RM.
Increases in weight per session were determined by subject capability and preference as well as
the ability to complete 4 sets of 4 repetitions of the given weight. Fatigue was measured each
session using the Visual Analog Fatigue Scale (VAFS) and weekly with the FSS.
Results: 7 subjects (5 female, 2 male, EDSS 3.57) completed the 8 week MST protocol. There
were significant changes found in all objective measures from pre to post testing. (1RM, BBS,
and 6MWT). Right leg 1RM increased significantly by 82.86 pounds (F(1,6) = 20.26, p = .004),
and left leg 1RM increased significantly by 72.14 pounds (F(1,6) = 63.03, p < .001). The BBS
increased significantly by 5.28 points (F(1,6) = 15.56, p = .008). The 6MWT increased
significantly by 150.69 feet (F(1,6) = 6.35, p = .045). Subjective perceptions of fatigue while
walking were not significantly different for the two walking conditions.
Conclusion: All subjects who completed the study did so without any adverse effects.
Significant improvements were seen in all objective measures (1RM, BBS, and 6MWT)
following the MST protocol. This suggests that MST may be a safe and effective measure to
improve gait and endurance in PwMS.
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INTRODUCTION
Multiple Sclerosis is a variable and degenerative neurological disease that commonly
causes impaired gait and balance, fatigue, decreased strength, spasticity, range of motion and
coordination (Induruwa, Constantinescu, & Gran, 2012; LaRocca, 2011; Ng, Miller, Gelinas, &
Kent-Braun, 2004). The etiology of MS is the demyelination of axons and formation of
inflammatory plaque in the central nervous system (CNS) (Frohman, Racke, & Raine, 2006).
The severity of the disease varies tremendously between persons, as well as where the
demyelination occurs in the CNS (Frohman et al., 2006), however some symptoms are prominent
and generally applicable to PwMS. MS-related fatigue is a prominent symptom of MS that can
lead to gait impairments and a decrease in time dedicated to exercise, thus posing a unique
challenge to both the patient and physical therapist (Karpatkin et al, 2013). Most progressive
resistive exercise (PRE) interventions, which generally require three sets of at least 8-12
repetitions, may be too fatiguing for MS patients to complete. As a result, PwMS may not be
able to build significant strength and counteract the neural interruptions caused by the disease
that limit their functional activities. Consequently, there is difficulty finding consistently
effective interventions to address the functional limitations due to the heterogeneity of the
disease (Karpatkin, 2005; Lucchinetti et al., 2000).
Strength training programs utilizing mild to moderate intensity are commonly prescribed
to address many of the deficits found in MS. Studies applying mild to moderate intensity
strengthening programs to PwMS provided inconsistent results regarding the exercise programs’
effects on their gait and balance (DeBolt & McCubbin, 2004; de Souza-Teixeira et al., 2009).
Maximal strength training (MST), which involves lifting nearly maximal weights (85-95% of
one repetition maximum [1RM]) with low repetitions, has been shown to improve functional
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abilities in both healthy and non-MS impaired populations (Mosti et al., 2014; Mosti, Kaehler,
Stunes, Hoff, & Syversen, 2013; Piacentini et al., 2013; Østerås, Helgerud, & Hoff, 2002; Hill et
al., 2012; Hoff et al., 2007). An MST protocol could serve as a good method of combatting the
fatigue that often sets in with strength programs that require higher repetitions or longer time
intervals due to its short duration and low repetitions. To date there is one study that has
examined the use of MST in PwMS, but its relationship to functional measures was not assessed
(Fimland, Helgerud, Gruber, Leivseth, & Hoff, 2010). The purpose of this study was to examine
the effects of MST on gait and balance in PwMS. We hypothesized that MST would result in
improved gait and balance measurements in PwMS, and if our hypothesis was correct, it would
suggest that MST can be an effective means of treating functional limitations in PwMS. The null
hypothesis for this study was that MST would not result in improved gait and balance
measurements in PwMS.
Use of MST in Healthy Populations
MST was effectively utilized in non-pathological populations and resulted in
improvements in strength, endurance, rate of force development (RFD), running economy, and
bone mineral density (BMD) (Mosti et al, 2014; Østerås et al, 2002; Piacentini et al, 2013).
Østerås et al. (2002) used an MST protocol to examine whether an increase in exercise economy
was due to a change in the force-velocity relationship and mechanical power output of the
musculoskeletal system. A group of 19 cross-country skiers were randomly assigned to an MST
or control group. The MST group trained for 15 minutes, three times per week, for nine weeks,
with an emphasis on increasing neural adaptations instead of muscle hypertrophy, as supported
by Almåsbakk and Hoff (1996), who found that the use of short, explosive movements in an
exercise program could promote a greater increase in strength via neural adaptations compared to
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muscle hypertrophy. The MST groups’ protocol consisted of three sets of five repetitions using
85% of their 1RM, whereas the control group was allowed to participate in traditional strength
endurance training only, which was defined as lifting less than 85% of their 1RM. The primary
outcome measures for both groups were 1RM, time to exhaustion, peak power, and RFD. The
high resistance group’s 1RM and time to exhaustion significantly increased on average by 22%
and 61%, respectively, while peak power and RFD also increased significantly. The control
group showed no significant differences for any primary outcome measures, allowing the authors
to conclude that the increase in peak power and RFD rather than the increase in 1RM
specifically, might be more responsible for the improved endurance performance.
Mosti et al. (2014) examined the effects of MST versus general exercise
recommendations on changes in bone mass density (BMD) and strength in young adult females.
30 females were randomly assigned to either the MST (n=15) or control group (n=15) for the 12
week intervention. The MST group performed 4 sets of 3-5 repetitions on a hack squat exercise
machine, with an emphasis on an explosive concentric contraction followed by a controlled
eccentric motion. The control group was encouraged to participate in exercise on their own time
as recommended by the American College of Sports Medicine (ACSM). Following the
intervention, only the MST demonstrated statistically significant improvements in BMD as
measured by dual-energy x-ray absorptiometry of the lumbar spine and hip. In addition, the MST
group had greater improvements in RFD and 1RM compared with the control group, with the
authors suggesting the changes were most likely due to a more efficient neuromuscular system.
This is a common explanation given for the changes seen due to the intensity and duration of the
exercise program.
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Piacentini et al. (2013) examined the effects of a variety of strength training programs,
including MST, over a 6 week period on master endurance runners and their performance.
Master athletes differ from conventional or professional athletes in that they are generally older
(e.g. 35 and older), and have busy schedules from non-running related work and/or family duties.
MST was compared to standard resistance training (RT) and endurance training, with the
author’s looking at the changes in 1RM, running economy, body composition, and functional
movements such as a squat jump and countermovement jump. Both training groups performed
multiple lower and upper extremity exercises on different days, twice a week, in addition to their
regular running program. The MST group did 4 sets of 3-4 repetitions at 85-90% of their 1RM,
while the RT group performed 3 sets of 10 repetitions at 70% of their 1RM. The control group
performed only endurance training in addition to their regular running program. Following the 6
week intervention, the MST group had the most significant changes in the areas of 1RM and
running economy at a marathon level pace, whereas the RT group was the only one to have
improvements in squat jump and countermovement jump. There were no changes in body
composition following the intervention, with the author’s concluding the changes found were
most likely due to neurological mechanisms. The positive improvements in master athletes from
utilizing a MST program include not only a more efficient neuromuscular system, but also a
program that can build strength for those who perform high levels of endurance exercise in a safe
and effective way.
Use of MST in Non-Neuropathological Populations
MST was found to improve walking performance in non-neuropathological populations
such as peripheral arterial disease (PAD) and chronic obstructive pulmonary disease (COPD).
MST has also been demonstrated to be effective in restoring strength in the operative limb for
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those undergoing total hip arthroplasties (Husby et al., 2009). Wang et al. (2010) examined the
effects of MST on walking performance in individuals with PAD, as measured by RFD, walking
economy, and time to exhaustion. Ten subjects with Fontaine stage II (mild) PAD were recruited
for this nonrandomized study, and served as their own controls for eight weeks prior to
beginning an eight week MST exercise program. The MST program consisted of a 10-minute
warm-up on a treadmill at a patient selected speed prior to performing four sets of four
repetitions at 85-90% of their 1RM on a horizontal leg press machine. The subjects trained three
times a week over the eight-week period, with all patients completing the program. Following 8
weeks of MST, there were significant improvements in the subjects’ RFD, walking economy,
and time to exhaustion. The findings of Wang et al. (2010) were consistent with Østerås et al.
(2002), suggesting that very high load, low repetition programs could not only increase strength,
but also help with muscular endurance.
Hoff et al. (2006) examined MST effects on mechanical efficiency, as measured by the
ratio of work performed to oxygen consumption, in persons with COPD. Twelve subjects were
chosen on the basis of fitting the clinical definition of COPD of GOLD guidelines between 40
and 70 years of age with FEV1/FVC < 70% and FEV1 < 60%, with six subjects in the MST
group and six subjects assigned to the control group. The MST program consisted of subjects
performing four sets of five repetitions on a horizontal leg press machine at 85-90% of their
1RM, three days a week. The primary outcome measures were pulmonary function, RFD, 1RM,
and peak force. Only the MST group showed significant changes following the program, with a
21.5% improvement in FEV1, 10% improvement in FVC, in addition to improvements of 83.2%
in RFD, 27.1% in 1RM, and 13.4% in peak force. The measure for mechanical efficiency after
the MST program intervention also showed statistically significant improvements of 31.3%.
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Although this study demonstrates that MST is well tolerated in the COPD population, similar to
the outcome found by Wang et al. (2010), Mosti et al. (2014), and Østerås et al. (2002),
functional measures such as gait and balance were not assessed.
Husby et al. (2009) compared the effects of a four week intervention using MST and
conventional rehabilitation on patients’ one week status post total hip arthroplasty (THA) lateral
approach versus only conventional rehabilitation on strength, RFD, gait parameters, work
efficiency, and quality of life measurements. The MST group performed 4 sets of 5 repetitions at
85% of their 1RM on a leg press machine and standing cable abduction exercises, as well as
conventional rehabilitation, which included sling exercise therapy for the hip in the sagittal and
frontal planes with sets of 12-15 repetitions. The conventional rehabilitation occurred five days a
week for both groups, with the MST group also performing the leg press and abduction exercises
five times a week for one hour per session. Following the intervention, the authors noted both
groups had demonstrated improvements in their 1RM for both exercises and overall RFD, but the
MST group had significantly greater changes. Work efficiency, which is a percentage of the total
energy expended during a specific task, had a greater trend in the MST group at posttesting
compared to the conventional rehabilitation group. Gait parameters and quality of life scores
were however, not statistically significant between groups. The positive changes observed in
subjects’ 1RM as well as trend towards a greater work efficiency during this short 4 week
intervention likely resulted from some plastic changes in the nervous system due to the duration
of the study. MST appears to not only be safe for patients 1 week following a THA, but also very
effective in restoring strength during the acute to subacute phases of recovery.
Use of MST in Neuropathological Populations
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Examining past studies’ use of MST in neuropathological populations was important to
support the effectiveness and safety of MST in PwMS. Criteria for the studies presented here
were focused upon the specificity of the MST protocol. Any study that did not use a weight
lifting protocol involving lifting 85-95% of one repetition maximum [1RM]) with four or five,
repetitions was specifically excluded from this review, except for studies that worked with
significant neurological populations and or whose protocol emphasized maximal strengthening
using a different methodology. The upcoming section will present studies which looked at the
effect of MST in persons with neuropathologies including schizophrenia, stroke, spinal cord
injury (SCI) and MS, of whose results led to improvements in various aspects including strength,
function, and neural drive.
Heggelund, Morken, Helgerud, Nilsberg, & Hoff (2012) examined the effects of MST on
walking efficiency in patients with schizophrenia. This non-randomized controlled pilot study
consisted of 6 schizophrenic subjects participating in the MST group and 7 schizophrenic
subjects playing computer games as the control. The study was conducted over an eight-week
period, with supervised interventions three times a week. The MST group performed a fiveminute warm-up on a treadmill at an intensity of 70% peak heart rate before performing four sets
of four repetitions at 85-90% of the subject’s 1RM on a leg press machine. Subjects in the MST
group increased their 1RM by 38%, improved their mechanical efficiency of walking, a
percentage of work input that is converted into work output, by 3.4%, and also decreased their
VO2 cost of walking. The strength gains and improved efficiency of walking seem to indicate
that MST could be used as an appropriate treatment for those with strength and gait deficits in
this patient population.
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Hill et al. (2012) examined the effectiveness of MST on lower extremity strength
function of chronic stroke survivors. Ten subjects were included if they walked independently,
and if their stroke occurred more than six months prior to the study. Prior to beginning the 8
week MST protocol, subjects served as their own control for four weeks to limit contributions
from other sources. The MST intervention consisted of four sets of four repetitions of 85-95% of
their 1 RM, doing unilateral plantarflexion and leg press via the horizontal leg press machine,
three days a week. The subjects’ 1RM significantly improved in both the plantarflexion and the
leg press exercises, with a notable 223% gain of the affected limb on the leg press. The 6 Minute
Walk Test (6MWT), Timed Up and Go Test (TUG), and Four Square Step Test (FSST) were
also utilized, with gains in all except the FSST. This study confirms that MST may be associated
with significant strength gains that also can carryover into function.
Fimland et al (2010) was the first to date to examine the effect of MST on the 1RM and
neural drive, via EMG, in PwMS. Fourteen PwMS were recruited, pretested, and evenly
randomized to a MST group or a control group. Both the MST and control group participated in
conventional rehabilitation exercises (aqua gymnastics, stretching, physical therapy, and
relaxation techniques). The MST group additionally participated in a specific MST training
regime five times per week for three weeks. The training regime consisted of four sets of four
repetitions at 85-90% of their 1RM of unilateral leg press and seated calf raises, similar to the
study by Hill et al. (2009). The primary outcome measures included maximum voluntary
isometric plantar flexor contractions (MVCs) and surface electromyography measurements
(EMG) (Root mean square [RMS], M-wave, H-reflex, and V-wave) of the soleus muscle. The
M-wave is the initial response to muscle stimulation, the H-reflex measures the monosynaptic
reflex, and the V-wave is an electrophysiological variant of the H-reflex, which is supposed to
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measure descending neural to motor neurons (Fimland et al., 2010). MVC and soleus RMS EMG
activity increased significantly by 20% and 36%, respectively in the MST group, while no
significant changes were seen in the control group. The MST group observed changes in the Vwave, with the control group not measuring any EMG changes The significance of this study was
that it was the first that showed an increase in efferent outflow to spinal motor neurons to the
lower limb muscles in PwMS as a result of a strength-training program, as evidenced by positive
changes in V-wave values. This suggests that there may be a unique firing pattern in the central
nervous system that happens with MST as compared to mild and moderate strength training
programs.
An observational, cross sectional study by Broekmans et al (2012), further contributes to
the theory that maximal strength, rather than submaximal, may be a stronger contributor to
increased function (Eek et al., 2008). Broekmans et al. (2012) examined the correlation between
modes of maximal strength contractions and the walking capacity of PwMS. Fifty two
participants, diagnosed with MS, were included with mild to moderate disease (scores 1.5 and
6.5 on the Expanded Disability Status Scale [EDSS]). The different modes of maximal strength
included maximal isometric torque, maximal isokinetic torque, and maximal isokinetic muscular
endurance, measured via a dynamometer. Walking capacity was measured via functional
measures including the TUG, the Timed 25 Foot Walk Test (T25FW), and the Two Minute Walk
Test (2MWT). Between the two subgroups, there were stronger correlations between strength
and walking capacity in persons with moderate ambulatory dysfunction. For those with moderate
ambulatory dysfunction, there were only significant correlations between muscle endurance and
all walking tests. Knee-flexor isometric strength, of both subgroups, had a higher correlation
with the walking tests than knee extensor isometric strength. Although this study did not use
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MST, defined as 4 sets of 4-5 repetitions, lifting 85-95% of the 1 RM, it did examine the effect
of maximal effort during exercise on functional gains in PwMS.
Jayaraman, Thompson, Rymer, & Hornby (2013) purposefully utilized a short duration
study to emphasize neurological gains rather than hypertrophy, which impact strength
improvement if applied in eight weeks or less. The study compared the effects of a 4 week
maximal intensity resistance program (MAX), utilizing isometric contractions versus a
progressive resistive exercise (PRE) program, on functional measures in persons with chronic,
incomplete SCI. Their methodology differed from the MST studies previously discussed in that
they used maximal isometric contractions instead of isotonic contractions, as well as 3 sets of 10
repetitions instead of 4 sets of 4 repetitions, but their goal was to still stress the patient’s nervous
system at their highest level. Positive changes were noted in the BBS only in the MAX group, as
well as improvements in 6MWT times and Modified Ashworth scores. The authors stated they
purposefully utilized a short duration study to try and emphasize neurological gains, as the
nervous system has been shown to have the greatest impact on strength changes in less than 8
weeks duration. The results of this study may indicate that positive neurological changes in
strength and functional measures could actually be seen in a variety of maximal intensity training
programs. The common denominator in this study and the previously discussed MST studies
reviewed appears to be maximum intensity training. A MST protocol however, may be more
functional in that it utilizes isotonic muscle contractions, and requires extremities to move
throughout their full ROM, whereas isometric contractions generally only result in strength
changes in the specific angle strengthened in.
Conclusion
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The literature demonstrates that maximal strength training can translate into increased
strength and improved functional measures. The study by Hill et al. (2012) used an MST
protocol defined as 85%-95% of ones 1RM, however, other studies referenced here utilized
varying approaches to strengthening at maximal strength. The positive effects of MST were
observed in the aforementioned nonpathological, non-neuropathological, and neuropathological
populations. The study by Fimland et al. (2010) is the only one to date that has examined the
impact of MST on PwMS, but no subjective or functional measures were implemented. The
purpose of this study was to examine the impact of MST on PwMS using functional measures,
specifically those in gait and balance. We hypothesized that MST would result in improved gait
and balance; therefore, it would suggest that MST could be an effective mode of treating some of
the functional limitations present in persons with MS. Our null hypothesis was that MST would
not result in improved gait and balance in PwMS.
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METHODOLOGY
Subjects
Eight subjects were recruited for this pilot study based off of flyers that were present in a
MS specialty office, where the lead investigator currently practices. The inclusionary criteria
consisted of a positive diagnosis of MS, the ability to ambulate for 6 minutes with or without an
assistive device, and the ability to understand and sign an informed consent form. Exclusionary
criteria included any type of orthopedic or cardiopulmonary condition restricting the ability to
walk for 6 minutes, any exacerbations, either immediately prior (2 weeks or less) or during the
study, or any cognitive issues that would prevent them from following instructions on how to
perform the exercises and tests.
The demographics of the subjects included the years since the MS diagnosis, their EDSS,
age, gender, medications (if any), if they use an assistive device (AD), baseline fatigue according
to the Fatigue Severity Scale (FSS), and fatigue before and after each session, as determined by
the Visual Analog Fatigue Scale (VAFS). The EDSS is the most widely used scale for PwMS in
determining their level of impairment (Amato & Ponziani, 1999; Kurtzke, 2008). The FSS has
also been verified as an accurate method of measuring fatigue in PwMS (Learmonth et al., 2013).
The VAFS has been successful in measuring fatigue on a daily basis, as opposed to the FSS,
which is a better indicator of fatigue over longer periods of time (Shah, 2009; Flachenecker et
al., 2002).
Design
The design of this study used a similar protocol to that of Hill et al. (2012), which
examined the effects of MST in chronic stroke survivors. Each subject performed four sets of
four repetitions at 85-95% of their 1RM using a horizontal leg press machine, two days per
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week, over the course of an 8 week training period. The 1RM, the Berg Balance Scale (BBS),
and 6MWT were the primary outcome measures, with the VAFS and FSS used as secondary
subjective measurements.
All sessions took place at Hunter College’s Physical Therapy department, with the lead
investigator and at least one student physical therapist present during each participant’s session.
During the first session, the BBS and 6MWT were used to establish baseline values. Both have
been verified as reliable tests to assess balance and endurance in PwMS (Cattaneo, Regola, &
Meotti, 2006; Goldman, Marrie, & Cohen, 2008). The BBS was performed first to avoid
significantly fatiguing subjects, and a five minute rest period was given after each test to allow
for adequate recovery. To determine each subject’s 1RM, subjects were first familiarized with
the horizontal leg press machine and set up with their hips and knees aligned at 90 degree angles.
Once in proper alignment, subjects began with minimal weight while performing unilateral leg
press extensions in order to gain comfort in performing the exercise. The load was then increased
to a level that the subject felt was about 50-75% of their maximum capacity. Single repetitions
were performed with increasing weight (5-10 lbs) until only 1 repetition could be completed. The
single repetition was determined as their 1RM. This protocol has been previously performed with
PwMS in a study by Fimland et al. (2010) and is recommended by the American College of
Sports and Medicine (2013). This concluded the initial visit and baseline assessment.
For the 8 week intervention, an aerobic warm-up was performed for 5 minutes on a cycle
ergometer at a comfortable pace as decided by the subject. After completion of the warm-up, five
minutes of rest were given to normalize blood pressure, and then subjects performed a muscular
warmup of five repetitions on the leg press machine at 50% intensity of their 1RM. 90 seconds
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after the muscular warmup, subjects began the MST regimen, consisting of 4 sets of 4 repetitions
at 85-95% of their 1RM for each leg, with 90 second breaks in between sets.
Subjects were instructed to perform an explosive concentric contraction followed by a
slower controlled eccentric contraction, such that the time spent was in a 1:2 time ratio,
respectively. Subjects were also told to pause a full second before performing the next repetition
to avoid elastic energy contribution to the movement, and instructed not to hold their breath in
order to prevent the Valsalva maneuver from occurring. The Valsalva maneuver causes a
significant increase in intraabdominal and intrathoracic pressure, which would assist in the lift,
but could potentially lead to a significant decrease in blood pressure and syncope. If subjects
were able to perform all 4 sets of 4 repetitions at the designated weight, and felt they could
perform a fifth repetition, the weight was increased by 2.5-5 lbs at the next session, with the
increase determined by subject capability and clinical judgment of the researchers.
At the end of each session of four sets of four repetitions, a cool down was performed on the
cycle ergometer for five minutes. Fatigue was measured using the VAFS before and after the
MST regimen in each session, with the FSS filled out on a weekly basis. Scheduling varied for
each participant over their 8 week program, but there was at least one day of complete rest before
returning for the second session of the week. At the end of the eight week training program,
subjects performed each of the individual outcome measures including, 6MWT, BBS, and 1RM
test, concluding the experimental portion of the study. If any of the subjects were uncomfortable
or felt the need to stop for any reason at any point during a session, the session would have
ended. If more than one incident occurred, or if an exacerbation developed, the participant would
have been removed from the study.
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STATISTICAL ANALYSIS
Analyses were performed with SPSS version 12.0 (SPSS, Chicago, IL). Mean values were
calculated for all variables and participant characteristics. The statistical analysis used in the
study was a repeated-measures multivariate analysis of variance (MANOVA) was conducted.
Because the repeated-measures MANOVA involved just two levels of repeated measures, the
assumption of sphericity was not relevant to this analysis. Due to the small sample size,
bootstrapping (using a replication sample of 1000) was employed; bootstrapping is a relatively
common statistical procedure in MS studies, including clinical trials, with small samples
(Humphreys, Drummond, Phillips, & Lincoln, 2013; Palacios, Alonso, Bronnum-Hansen, &
Ascherio, 2011; Saxton et al., 2013). A p-value of 0.05 was used to determine if the results are
significant. This repeated-measures MANOVA was used for each variable including the 6MWT
time, BBS scores, 1RM, FSS, and VAFS. Each subject was asked to fill out a VAFS before and
after each session. VAFS consists of a 10 cm horizontal line with written descriptions at each
end; subjects were asked to mark on the line the point that they feel represents their perception of
their current state of fatigue. The possible score ranges from 0 to 100, measured in millimeters
on a 10 cm vertical line using a pen (Tseng, Gajewski, & Kluding, 2010). The changes in the
VAFS scores throughout each subjects training protocol was tested for significance using
repeated-measures MANOVA.
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RESULTS
Demographics and Subject Characteristics
Eight subjects participated in the study and seven completed the MST training protocol.
Initially, one subject dropped out due to unrelated reasons. Second, one of the remaining seven
participants completed only 7 out of the 8 weeks of the MST protocol due to scheduling
complications. Four subjects completed all 16 MST training sessions, two subjects completed
15MST training sessions, and one subject completed 14 MST training sessions. This means
subjects completed 96.43% of training. Of the subjects who completed the training, the mean
age was 51.57 years (+12.74, range 34-69 years), the mean number of years since diagnosis was
14.29 years (+14.29, range 3-35 years), mean EDSS was 3.57 (+1.23, range 2.5-6), and mean
MSIS29 was 69.14 (+18.44, range 43-92). Two subjects were male; five were female. Five
subjects walked with an assistive device; four used anti-fatigue medications, and three used antispasticity medication. These values are summarized in Table 1.
x̅ 51.57, range 34-69 years (+12.74)

Age, mean (SD)
Gender
Male
Female

2
5
x̅ 3.57, range 2.5-6 (+1.23)

EDSS Score, mean (SD)
Type of MS
PP
RR
SP
Taking Anti-fatigue Meds
Taking Anti-spasticity Meds
MSIS29 Score, mean (SD)
Years since dx, mean (SD)

1
2
4
4
3
x̅ 69.14, range 43-92 (+18.44)
x̅ 14.29, range 3-35 years (+11.67)

Table 1: Demographics and Clinical Characteristics of Participants (n=7)
MS, Multiple Sclerosis; EDSS, Expanded Disability Status Scale; MSIS29, Multiple Sclerosis Impact Scale; RR,
relapsing-remitting; SP, secondary progressive; PP, primary progressive

One Repetition Maximum (1RM) Scores
All results were analyzed using a group mean average of pre and post testing 1RM
measurements. Right sided 1RM significantly increased from pretest (M = 146.07, SD = 93.36)
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to posttest (M = 228.93, SD = 95.98), F(1,6) = 20.26, p = .004, partial η2 = .772 (Figure 1). This
was an increase of 82.86 pounds in right sided leg strength. Left sided 1RM increased even more
significantly from pretest (M = 142.86, SD = 100.87) to posttest (M = 215.00, SD = 114.07),
F(1,6) = 63.03, p < .001, partial η2 = .913 (Figure 1). This was an increase of 72.14 pounds in
left sided leg strength.
Individual 1RM pre to post test measurement values are represented in the tables and
figures below (Table 2, Table 3, Figure 2, Figure 3, Figure 4)

Subject #
1
2
4
5
6
7
8

One Repetition Maximum (1RM): Right Lower Extremity (lbs)
Pre-Test
Post-Test
1RM Change in
1RM Change in %
lbs
100
220
+120
+120%
145
267.5
+122.5
+84.5%
60
75
+15
+25%
85
180
+95
+112%
325
395
+70
+22%
95
230
+135
+142%
212.5
235
+22.5
+11%

Table 2: Pre & Post Test Right Leg One Repetition Maximum (Individual Values & Percent Increases); 1RM, One
Repetition Maximum

Subject #
1
2
4
5
6
7
8

One Repetition Maximum (1RM): Left Lower Extremity (lbs)
Pre-Test
Post-Test
1RM Change in
1RM Change in %
lbs
30
62.5
+32.5
+108%
170
272.5
+102.5
+60%
125
177.5
+52.5
+42%
80
150
+70
+87.5%
325
420
+95
+29%
75
167.5
+92.5
+123%
185
255
+70
+38%

Table 3: Pre & Post Test Left Leg One Repetition Maximum (Individual Values & Percent Increases); 1RM, One
Repetition Maximum
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1 Repetition Maximum (1RM)

250

229

215

200
146

150
Pounds (Lbs)
100

143
Pre-Test
Post-Test

50
0
Right Leg

Left Leg

Figure 1: Pre & Post Test Unilateral Strength Change (Group Mean Values); 1RM, One Repetition Maximum

1 Repetition Maximum (1RM)
140
120
100
Percent 80
Increase 60
40
20
0

Right Leg
Left Leg

1

2

4

5

6

7

8

Subject #
Figure 2: Pre & Post Test 1RM Percent Increase (Individual Values); 1RM, One Repetition Maximum
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Right Leg 1 Repetition Maximum (1RM)

400
350
300
250
Pounds (Lbs)200
150
100
50
0

Pre Test
Post Test

1

2

4

5

6

7

8

Subject #
Figure 3: Pre & Post Test Right Leg 1RM (Individual Values); 1RM, One Repetition Maximum

Left Leg 1 Repetition Maximum (1RM)
450
400
350
300
Pounds (Lbs)250
200
150
100
50
0

Pre Test
Post Test

1

2

4

5

6

7

8

Subject #
Figure 4: Pre & Post Test Left Leg 1RM (Individual Values); 1RM, One Repetition Maximum

Week-by-Week Differences Regarding IRM
Bootstrapped Friedman’s tests were conducted to determine if the amount of weight (in
pounds) lifted (using both the right and left leg) significantly increased in increments over the
eight-week study period. Tests were conducted for the right and left legs for weekly sessions 1
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and 2. The first Friedman test analyzed incremental weight increases for the right leg for weekly
session 1 and was found to be significant, χ²(7) = 48.13, p < .001. The amount of weight (in
pounds) that participants lifted significantly increased incrementally over the eight-week study
period. The mean amount of weight lifted using the right leg during weekly session 1
significantly increased from M = 131.07 (SE = 31.73) at week 1 to M = 169.29 (SE = 31.81) at
week 8 (Figure 5).

Figure 5: Weight (in pounds) lifted using right leg (Session 1)

The second Friedman test assessed incremental weight increases for the left leg for
weekly session 1. Results were significant, χ²(7) = 47.28, p < .001. The amount of weight (in
pounds) that participants lifted significantly increased incrementally over the eight-week study
period. The mean amount of weight lifted using the right leg during weekly session 1
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significantly increased from week 1 (M = 127.43, SD = 33.19) to week 2 (M = 133.93, SE =
31.51), dropped to M = 123.57 (SE = 37.54) at week 3, but then continued to increase
incrementally over the eight weeks, ending at week 8 with an M = 159.64 (SE = 33.53) (Figure
6).

Figure 6: Weight (in pounds) lifted using left leg (Session 1)

Incremental increases in weight (in pounds) lifted using the right leg during weekly
session 2 were examined in the third Friedman test, which was found to be significant, χ²(7) =
47.21, p < .001. This significance, however, was influenced by an outlier at week 3 (Figure 7).
The third week data were removed and analyses were rerun.
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Figure 7: Weight (in pounds) using right leg (Session 2)

Results from the Friedman test remained significant when data from the third week were
removed, χ²(6) = 41.22, p < .001. The amount of weight (in pounds) that participants lifted
significantly increased incrementally over the eight-week study period. The mean amount of
weight lifted using the right leg during weekly session 2 significantly increased incrementally
from week 1 (M = 133.93, SE = 31.61) to week 8 (M = 172.86, SE = 31.61) (Figure 8).

22

Figure 8: Weight (in pounds) using right leg (Session 2) with week 3 data removed

The fourth and final bootstrapped Friedman test analyzed incremental weight increases
for the left leg for weekly session 2, and results were significant, χ²(7) = 47.81, p < .001. The
amount of weight (in pounds) that participants lifted significantly increased incrementally over
the eight-week study period. The mean amount of weight lifted using the left leg during weekly
session 2 significantly increased from week 1 (M = 129.57, SE = 87.65) to week 8 (M = 161.07,
SE = 87.95) (Figure 9).
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Figure 9: Weight (in pounds) using left leg (Session 2)

6 Minute Walk Test (6MWT) Scores
All results were analyzed using a group mean average of pre and post testing 6MWT
measurements. There were significant increases in total distance walked, measured in feet, from
pretest (M = 1040.04, SD = 429.25) to posttest (M = 1190.73, SD = 579.95), F(1,6) = 6.35, p =
.045, partial η2 = .514.6 (Figure 10). 6MWT scores improved 150.69 feet following the 8 week
MST protocol.
Individual 6MWT pre to post test measurement are represented in the tables and figures
below (Table 4, Figure 11)
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6 Minute Walk Test (6MWT) Individual Pre and Post Test Results (ft)
Subjects

Pre-Test

Post-Test

1
2
4
5
6
7
8

553
732.1
1071
1389.3
1733.1
1162.3
681.3

474.8
799.1
1188.4
1680.6
2103
1373.6
742.1

6MWT Change in
ft
-78.2
+67
+117.4
+291.3
+369.9
+211.3
+60.8

6MWT Change in
%
-14%
+9%
+11%
+21%
+21%
+18%
+9%

Table 4: Pre & Post Test 6MWT (Individual Values & Percent Increases); 6MWT, Six Minute Walk Test

6 Minute Walk Test (6MWT)
1191

1200
1150
Distance
Walked (Ft)1100
1050

Pre-Test

1040

Post-Test

1000
Group Average

Figure 10: Pre & Post Test 6MWT (Group Mean Values); 6MWT, Six Minute Walk Test
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6 Minute Walk Test (6MWT)
2200
1900
1600
Distance
Walked (Ft)1300
1000

Pre Test
Post Test

700
400
1

2

4

5

6

7

8

Subject #
Figure 11: Pre & Post Test 6MWT (Individual Values); 6MWT, Six Minute Walk Test

Group 6MWT minute-by-minute measurements were recorded but were not analyzed for
significance (Table 5).
Pre & Post Group 6MWT – Mean Minute by Minute Comparison (in ft)
1
2
3
4
5
Average
Pretest
Average
Posttest

6

184.19

365.85

539.46

707.39

879.32

1046.02

202.63

458.9

611.31

805.1

1004.73

1194.51

Table 5: Minute-by-Minute Pre & Post Test 6MWT (Group Mean Values); 6MWT, Six Minute Walk Test

Berg Balance Scale (BBS) Scores
All results were analyzed using a group mean average of pre and post testing BBS scores.
There were significant pre- (M = 44.29, SD = 8.34) to posttest (M = 49.57, SD = 5.83) increases
in balance, as measured by the Berg Balance Scale (BBS), F(1,6) = 15.56, p = .008, partial η2 =
.722 (Figure 12). BBS scores improved 5.3 points following the 8 week MST protocol.
Individual BBS pre to post test scores are represented in the tables and figures below
(Table 6, Figure13).
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Subjects

Berg Balance Scale (BBS)
Pre-Test
Post-Test

1
2
4
5
6
7
8

31
46
36
54
52
48
43

BBS Change

39
49
48
56
55
53
47

+8
+3
+12
+2
+3
+5
+4

Table 6: Pre & Post Test BBS (Individual Values); BBS, Berg Balance Scale

Berg Balance Scale (BBS)
55
49.6

50
45
Score
40

44.3
Pre-Test

Post-Test

35
30
Group Average
Figure 12: Pre & Post Test BBS (Group Mean Values); BBS, Berg Balance Scale
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Berg Balance Scale (BBS)
55
50
45
Score
40

Pre Test
Post Test

35
30
1

2

4

5

6

7

8

Subject #
Figure 13: Pre & Post Test BBS (Individual Values); BBS, Berg Balance Scale

Week-by-Week Differences in Fatigue Scores
A series of bootstrapped Friedman tests were conducted to determine if participants’
fatigue scores incrementally increased over the eight-week study period. Participant fatigue was
assessed using the Fatigue Severity Scale (FSS) and the Visual Analog Fatigue Scale (VAFS).
Fatigue as measured by the VAFS was examined at pretest and posttest for sessions 1 and 2.
The first bootstrapped Friedman test analyzed data from the FSS, and results were not
significant, χ²(7) = 13.15, p = .068. The FSS fatigue scores ranged from a low of M = 44.00 (SE
= 5.86) (at week 1) to a M = 53.00 (SE = 3.03) (at week 7). The FSS scores remained around M
= 48.50 for the remaining weeks.
A series of bootstrapped Friedman tests were then conducted on the VAFS, with analyses
conducted on pretest and posttest scores for Sessions 1 and 2. Results from the bootstrapped
Friedman test for pretest VAFS scores at session 1 were not significant, χ²(7) = 6.24, p = .512.
The VAFS fatigue scores increased from M = 33.00 (SE = 10.56) at week 1 to M = 40.60 (SE =
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13.08) at week 2. After week 2, however, the fatigue scores did not vary much from M = 41.00,
the exceptions being M = 49.00 during weeks 6 and 7. The bootstrapped Friedman test
conducted on the VAFS posttest scores for session 1 furthermore showed that fatigue did not
demonstrate any significant incremental increases over the eight-week study period, χ²(7) =
11.64, p = .113. The week 1 mean was 39.80 (SE = 6.64), which increased to M = 52.60 (SE =
8.43) at week 2. After week 2, fatigue scores started to incrementally decline. While fatigue
peaked during weeks 6 and 7 (with Ms of 55.00 and 59.80, respectively), the final week 8 mean
fatigue score of 52.60 (SE = 4.97) was the same as the mean for week 2.
A bootstrapped Friedman test was then conducted on the VAFS pretest scores for session
2, and it was found to be non-significant, χ²(7) = 5.88, p = .554. The VAFS fatigue scores
increased from M = 20.00 (SE = 9.50) at week 1 to M = 25.33 (SE = 12.41) at week 2, but the
fatigue scores did not vary much from a mean of 25.00 for the remaining weeks, the exception
being week 5, in which the mean was 38.67 (SE = 3.18), resulting from an outlier. The
bootstrapped Friedman test conducted on the VAFS posttest scores for Session 2 was not
significant, χ²(7) = 5.10, p = .647. While fatigue increased from M = 37.67 (SE = 2.33) at week
1 to M = 50.00 (SE = 3.00), after week 2 the fatigue scores actually began to incrementally
decrease. The fatigue mean score of M = 38.33 (SE = 8.09) at week 8 was very similar to the
fatigue mean score (M = 37.67, SE = 2.33) at week 1.
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DISCUSSION
Introduction
The present study hypothesized that an eight week MST protocol would result in
improved gait and balance measurements in PwMS. Our hypothesis was supported by significant
increases, represented by a group average, for all individual variables (1RM, BBS, and 6MWT)
following the MST protocol. Clinically, these results support the idea that therapists can utilize
maximal intensity training in PwMS to improve function in a safe and effective manner. In the
past, PwMS have been directed away from intensive exercise due to the fear of exacerbating
their fatigue, a significant symptom of MS. Not only did the participants demonstrate increases
in their 1RM and their functional outcomes, but there were no incidents of exacerbation or
injury, and no significant increases in fatigue throughout the study. The increase in subjects’
1RM, post MST training, were statistically significant, as they were in the initial MST study by
Fimland et al. (2010). The present study is the first, to the authors’ knowledge, to link these
significant changes in 1RM, following an MST protocol, to functional gains in balance and gait
(BBS and 6MWT) in PwMS.
Both clinical and statistical significance in functional measures were observed between
pre and post test outcomes measures. Clinically significant changes were seen in two subjects
who increased their 6MWT distance by 250 feet or more, and 2 subjects who increased their
BBS scores by 7 points or more. All subjects demonstrated statistically significant increases in
their 1RM at the conclusion of the eight week protocol. Statistically significant changes occurred
in BBS scores and 6MWT distances group averages. No significant increases occurred in fatigue
as measured using the VAFS and FSS. Possible reasons for these promising outcomes in this
pilot study will be discussed.
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MST – Changes in Neural Drive
In regards to strength improvements, the factor believed to be primarily responsible for
changes in subjects’ 1RM was improvement in neural drive, as opposed to muscle hypertrophy,
due to the limited duration of the exercise intervention. (Aagaard, Simonsen, Andersen,
Magnusson, & Dyhre-Poulsen, 2002). Neural drive has been previously defined as “the ensemble
of action potentials from a group of alpha motor neurons to the innervated muscle” (Farina &
Negro, 2012). With strength training, the increases in neural drive can influence the activation of
muscles through modulation or changes in motor unit recruitment, synchronization, firing
frequency, and inter-muscular coordination (Cormie et al., 2011). These neural changes are seen
earlier in a strengthening protocol unlike muscle hypertrophy, which is a slower process. It
generally takes at least six weeks to develop noticeable increases in cross sectional area, making
it unlikely to account for the large gains seen throughout this study’s protocol (Guilhem, Cornu,
& Guével, 2010; Folland, & Williams, 2007; Phillips, 2000). Even with changes in the muscle
fibers themselves, these changes were likely supplementary to the increased neural drive that
occurred throughout the exercise program. As previously defined, MS is a degenerative
neurological disease that results in the demyelination of axons and formation of inflammatory
plaque in the central nervous system (CNS) (Frohman, Racke, & Raine, 2006). It is a possibility
that this demyelination and plaque development could lead to a decrease in neural drive, which
would make MST an important type of exercise to consider, as it has been shown to improve
neural drive in both non-neuropathological, and neuropathological populations (Hill et al. 2012;
Hoff et al. 2006; Fimland et al 2010; Østerås et al. 2012; Mosti et al. 2014; Piacentini et al. 2013;
Wang et al. 2010). Fimland et al. (2010), utilized MST on PwMS, to increase neural drive during
a 3 week MST protocol and found increases in maximum voluntary contraction (MVCs) and
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surface EMG measurements via the V-wave of the soleus muscle pre to post MST intervention in
PwMS, indicating increased neural drive. Resistance training, in general, results in increased
motor unit firing frequency, which is correlated with a 300-1500% increase in force output
during ballistic contraction (Cormie et al, 2011). Increases in neural drive may be the factor that
links the strength gains seen in MST with improvement in function, as evidenced by the positive
changes in functional measures. This improvement in function is an overarching physical therapy
goal and MST may be effectively utilized in PwMS in attaining these goals.
CLINICAL IMPLICATIONS
Improved Function
The increase in lower extremity strength following the MST protocol was coupled with
functional improvements displayed by significant improvements on the BBS and the 6MWT.
This is a very substantial finding as improvements in function could impact quality of life to a
greater extent than an objective improvement in leg strength alone. The ability to show a possible
link between strength gains from an MST protocol with improvements in gait and balance
measurements could have a positive impact on the possibilities for treatment in PwMS. The
question then arises, why does a static intervention such as a unilateral leg press have a possible
carryover into dynamic functional activities like the BBS and 6MWT? The BBS is an objective
measure that focuses on postural control of an individual while the 6MWT is a measurement that
focuses primarily on gait endurance. Postural control and gait endurance are separate entities
requiring different neural mechanisms in order to perform each effectively. Possible neural
mechanisms for the improvements in the BBS and 6MWT include changes in rate of force
development and increase in work efficiency.
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Modulation of neural drive could play a role in the improvement on the BBS. One factor
influenced by increased neural drive is known as rate of force development (RFD). RFD has
been defined as the rate of rise of contractile force at the beginning of a muscle action (Aagaard
et al., 2002). RFD, is considered functionally important in situations where the time to develop
force is limited, such as restabilization of the body following a loss of balance (Tillin et al.
2012). The BBS is a measure of a subject's ability to maintain postural control throughout
various static and dynamic tasks. Some of the tasks on the BBS are time sensitive and require a
subject to complete a dynamic task within a specific time in order to receive a score of 4/4. For
example, one of the items on the BBS requires the subject to turn around in a full circle, pause,
then turn around in a full circle in the opposite direction. In order to achieve a 4/4 score, each full
turn must be completed in 4 seconds or less. Another item on the BBS requires the subject to
place each foot alternately on a step/stool until each foot has touched the step/stool 4 times. In
order to achieve a 4/4 score, the 8 touches must be completed in 20 seconds or less. An improved
RFD could influence a subject's ability to perform these dynamic tasks within the specified time.
As the time to complete such a task decreases, the time to develop the appropriate force becomes
more important. If the RFD can be directly influenced through a MST protocol of the lower
extremities, this may be a factor that accounts for the functional improvement seen on the BBS.
The increases seen in the 6MWT for this study could have occurred due to a variety of
mechanisms. Walking occurs at a rather typical pace that is energy efficient; if you walk slower
or faster than this rate, energy expenditure increases as a result of a loss of potential energy and
momentum (Nolan, Yarossi, & Ramanujam, 2013; Waters & Mulroy, 1999). In many
neurological pathologies, such as MS, gait is significantly altered in terms of kinematics and
kinetics, thus resulting in increased energy use to perform this task. During endurance

33

performances it is generally thought that by spending as little energy as possible at a given speed,
an individual can either save energy or increase speed and thus improve the endurance
performance (Heggelund et al. 2013). Resistance training has been shown to improve work
economy and endurance performance, although the exact variables responsible are unknown
(Aagaard and Andersen 2010). It does however, appear that maximal strength and RFD coincide
with improved work economy, which could have functional implications (Sunde et al. 2010).
Heggelund et al. (2013) found that MST using heavy loads and explosive performance improved
work economy by 31% in untrained and moderately trained men. In other words, an individual
will have the ability to perform more or the same amount of work with reduced effort following
an MST protocol.
Hip and knee extensors are the primary muscles used when performing a leg press and
are important for gait (Heggelund et al. 2013). Increasing their ability to generate force may have
contributed to faster ambulation speed because these muscles are important in ambulation, and
became more fatigue resistant to the task of walking (Heggelund et al. 2013). In this case, the
quality of gait may not have drastically changed, but their ability to perform the task may have
been less taxing on their system because they were able to use relatively less energy to perform
the task. The results of this study demonstrate that PwMS respond similarly to MST with
improvement in work economy as seen with the changes in the pre and post 6MWT results.
Another reason for the positive findings in functional measures from this study may have
resulted from strengthening weak or untrained muscles necessary for dynamic activities such as
gait and balance. This addresses the premise that correcting impairments will translate into
improved performance of functional measures. This contrasts with task specific training, which
holds that training responses/adaptations are tightly coupled to the mode, frequency, and duration
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of the exercise performed (Hawley, 2002). This means that the vast majority of training-induced
adaptations may have only occurred in those muscle fibers that have been recruited during the
exercise regimen, with little or no adaptive changes occurring in untrained musculature.
Furthermore, the principle of specificity predicts that the closer the training routine is to the
requirements of the desired outcome, the better will be the outcome (Hawley, 2008). This idea,
however, did not seem to hold true with the results of our protocol, as MST utilizing a unilateral
leg press appears to be an impairment based strengthening intervention. Yet, even with an
impairment based strengthening protocol, we found significant improvements in functional
measures following the MST protocol. A potential reason why a task specific training approach
may not be ideal for the MS population is that it requires a basic level of strength and functioning
to even attempt to perform the task successfully. Since the MST protocol utilized in this study
focused on the hip and knee extensors, muscles essential for gait, their ability to generate force
more efficiently may have been the reason for the possible carryover into function, as objectively
seen with the BBS and 6MWT results. The conventional leg press machine is not task specific,
and does not appear to have any objective correlation to gait and balance.
Safety
One of the most important aspects of any physical exercise program is that it is safe for
the participant, and with neurological conditions such as MS, it is imperative that patients are
managed appropriately by a skilled professional who understands their diagnosis and what is in
their best interest. Because of the significant weight utilized for MST, it may appear to be unsafe
for those with pathological conditions due to the stresses placed on the body, and only
appropriate for athletes and younger conditioned individuals. MST has been a successful
exercise protocol in the healthy and athletic populations, causing significant strength gains,
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improved exercise endurance, and improvements in functional measures (Mosti et al., 2014;
Østerås et al., 2002; Piacentini et al., 2013; Symons, Vandervoot, Rice, Overend, & Marsh,
2005). However, MST has also been shown to be safe and effective in neurological and nonneurological disabled populations (Hill et al., 2010; Hoff et al., 2006; Karlsen, Helgerud,
Støylen, Lauritsen, & Hoff, 2009; Mosti, Kaehler, Stunes, Hoff, & Syversen, 2013; Wang et al.,
2010). For our study, there were no adverse orthopedic events or reported neurological changes
during the performance of the intervention, confirming with other cited studies that MST is a
safe exercise protocol for use in a variety of patient populations. Only one subject dropped out of
the study due to a knee injury following a fall while getting out of bed. Since PwMS are at an
increased falls risk, the fall may have been an incidental finding, and not necessarily due to the
exercise protocol (Matsuda et al., 2011). This is an important finding of the study, as it adds to
the current body of evidence suggesting that maximal, high intensity resistance training, along
with typical submaximal resistance training, does not appear to have any relationship to MS
symptom exacerbations, and is in fact beneficial for PwMS (Pilutti, Platta, Motl, & LatimerCheung, 2014; Roppolo, Mulasso, Gollin, Bertolotto,& Ciairano, 2013; Sutherland & Andersen,
2001).
One of the reasons why the MST protocol using the horizontal leg press machine was
safe for PwMS may have been due to its implementation in a controlled, supervised
environment. The horizontal leg press was set up with hip and knee angles at approximately 90
degrees, and their feet shoulder width apart with slight external rotation at the ankles. The slight
inclination that is present with the horizontal leg press machine puts the spine in a more neutral
alignment, and mimics the squatting motion throughout the range of motion. The handle bars at
the side of the machine also allowed for subjects to maintain greater stability when performing
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the exercise through the range, further contributing to the safety of the leg press. These factors,
as well as having at least two members of the research group present, ensured that subjects were
consistently set up properly before and during each session, and allowed for monitoring and
discussion with subjects about potential issues or complaints. Under a supervised and controlled
environment, there does not appear to be any contraindications to performing MST using a
horizontal leg press machine for PwMS. As long as subjects are appropriately screened, setup,
and monitored by skilled professionals, this is a safe intervention that could be utilized in PwMS.
Lastly, the use of MST without appropriate staffing and supervision may not be unsafe
depending on the person and their level of independence. For example, one of our subjects’ final
1RM was 395 pounds. He was independent with all activities and may be able to utilize this in a
gym setting without help. In contrast, there were subjects who required assistive devices to
ambulate and needed help getting onto the leg press machine. For these individuals, it would not
be advised to perform this outside of a clinical setting. The widespread use of MST in the
physical therapy and/or strength and conditioning realm would thus be limited depending on the
environment of the clinic or gym, the knowledge of the clinician(s), and appropriate staffing. The
general time frame to perform MST also needs to be considered, as it takes about 20-25 minutes
to complete, which may or not be feasible for certain offices along with all other necessary
treatments.
Fatigue
Measuring the potential impact MST has on fatigue is important as it is a prevalent
symptom in PwMS (Flachenecker et al, 2002). The two subjective fatigue outcome measures
utilized included the Visual Analog Fatigue Scale (VAFS), which measured short term fatigue,
and the Fatigue Severity Scale (FSS), which looked at more chronic effects of fatigue over a
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period as long as week (Flachenecker et al., 2002; Shah, 2009). MS related fatigue has been
defined as “A subjective lack of physical and/or mental energy that is perceived by the individual
or caregiver to interfere with usual and desired activities.” (Multiple Sclerosis Council for
Clinical Practice Guidelines, 1998). Exercise induced fatigue as defined in the non-MS
population, has been defined as “any exercise-induced reduction in the capacity to generate force
or power output” (Vøllestad, 1997). Both fatigue types affect PwMS and are difficult to
objectively differentiate, however participants’ report of feeling less fatigued after MST sessions
is a promising indication.
An important reason for choosing maximal strength training as an intervention for PwMS
is its short duration, which may avoid fatigue (Karpatkin et al, 2012). Karpatkin et al.
demonstrated that intermittent ambulation demands on PwMS were less fatigue inducing than
continuous ambulation, we hypothesized that MST, which is a strength protocol of short duration
and consistent 90 second breaks between sets, will not exacerbate fatigue. A unique
characteristic of the MST protocol is that it is very short in duration and very high in intensity
compared to traditional resistance exercise programs, which use moderate repetitions and
intensity values. MST at 85-95% of their 1 RM requires a participant to do 4 repetitions each set
while submaximal training may require anywhere between 8-15 repetitions per set, at a weight
that enables this many repetitions. A submaximal training program that requires more repetitions
is more time consuming, and is more likely to elicit time dependent fatigue. Fatigue is the most
common symptom for PwMS, it should therefore be a goal of clinicians to limit this occurrence
whenever possible to maximize their ability to participate in exercise, as well as to perform daily
activities. Ambulation for example, requires alternating flexion and extension contractions across
joints, however, with the onset of neuromuscular fatigue comes the inefficient co-contraction of
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muscles, limiting gait (Ranieri & Di Lazzaro, 2012). The MST protocol in this study used a total
of only 21 repetitions per leg in each session, including the warm-up, lasting less than 20 minutes
of actual weight lifting of loads at maximal intensities (85-95% of their 1RM). This suggests that
the work performed, even with lower repetitions, could be similar or greater than programs with
lower loads and greater repetitions, but over a much shorter period of time. The short nature of
MST and the 90 second rest period in between sets, may avoid the onset of neuromuscular
fatigue and allow patients to work on more efficient flexion and extension patterns, which may
have contributed to their faster walking speed evidenced by increased 6MWT times and better
balance as evidenced by increased BBS scores. One of the mechanism by which MST works for
PwMS, is that it may avoid fatigue due to limits exercise duration time, while allowing them to
reap the benefits of a rigorous MST program.
The purpose of conducting the intervention during the winter months was to decrease the
chances of causing heat induced fatigue, common in PwMS (Cantor, 2010). Heat can
significantly alter one's level of fatigue, and limit their ability to perform their typical and desired
activities. Exercising by its very nature results in increased body temperature, and this has led to
the finding that temperature increases with exercise may increase their perception of fatigue,
limiting their ability to participate in exercise programs (Sutherland et al., 2001). This theory
however, is not consistent with research examining the effects of exercise on PwMS. Petajan et
al. (1996) for example, demonstrated that PwMS could not only tolerate aerobic exercise, but
benefit from its effects physiologically and psychologically, as evidenced by increases in aerobic
capacity, strength in both their lower and upper extremities, and positive changes in their quality
of life. Due to the insignificant increase in reported fatigue by our subjects we can add to the
research that supports that integrating strength training into the treatment plan for PwMS is a
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means of maintaining strength, endurance, participation in activities of daily living, and
promoting psychological health (Motl & Pilutti, 2012).
Psychological Impact
The psychological profiles of many PwMS may be affected from the initial discovery of
their diagnosis, including the onset of depression and a perception of limited abilities, including
the inability to exercise and receive its benefits (Roppolo et al., 2013; Kasser & Kosma, 2012;
Jensen, Molton, Gertz, Bombardier, & Rosenberg, 2012). As a result of inactivity from
psychological changes, there may be significant functional changes that could negatively affect
their quality of life. This may include difficulty ambulating inside and outside the home,
transferring from various surfaces, limited working hours due to fatigue and weakness, as well as
sexual and/or hygienic issues (Sutherland et al., 2001). Therefore, symptoms of depression
should be addressed to help mitigate secondary changes that could occur. Two recent review
articles discussed the effects of exercise on depression, with both studies indicating that exercise
may have the potential to provide a reduction in depressive symptoms (Dalgas,, Stenager, Sloth,
& Stenager, 2014; Ensari, Motl, & Pilutti, 2014). This is an important finding, as exercise can
serve not only as a means to improve strength and lead to improvements in functional measures
as shown in the present study using MST, but also as a way to reduce and/or mitigate depressive
symptoms. MST can then, be safely utilized as an appropriate exercise program that could
address the depressive issues PwMS may experience. Psychological measures were however, not
utilized in the present study, limiting the direct effects MST may have had on psychological
profiles.
In our study, many subjects were extremely surprised from the initial evaluation to the
end of the study at how much weight they were able to lift using each leg on the horizontal leg
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press. The general comments that were made by the subjects reflected perceptions of overall
weakness because of their diagnosis of MS. These responses from the subjects were consistent
throughout the study, and suggest the possibility of a psychological component in their ability to
lift heavy weights and exercise regularly. The clinical implication from this is that clinicians
treating PwMS should not assume one is weak or cannot perform a specific task just because
they have MS. Their perceptions of what they can and cannot do may be misaligned with reality
for a number of reasons, requiring the clinician to investigate the cause of such thoughts and
thoroughly assess their ability to perform specific tasks. In addition, seeing progression with the
weight lifted throughout the study as well as having a regular exercise program may have
contributed to a positive perception of their abilities to perform high intensity exercises, and thus
improvement in the functional areas examined.
Spasticity
Considering whether spasticity would impact participants during the MST intervention
was important since it affects 40-60% of PwMS (Beard et al, 2003). In addition, participants in a
study by Balantrapu et al (2014), demonstrated that participants with higher levels of spasticity
had lower 6MWT, TUG, and timed 25 foot walk (T25FW) scores. Spasticity is an upper motor
neuron sign and is observed as hyperexcitability of the stretch reflex (Mukherjee, 2010).
Spasticity has been documented to be more responsible for causing lower extremity disability
rather than decreased strength (Beard et al, 2003). If this is the case, than strengthening spastic
lower extremities may not be contraindicated, as long as this UMN sign is not elicited mid
intervention.
Spasticity is elicited by passive/static stretching of muscles as well as dynamic muscle
stretch by muscle and tendon jerks (Mukherjee, 2010). MST utilizing a leg press machine
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demands an active ballistic extension of the hips, knees, and ankles which through reciprocal
inhibition, inhibits firing of muscles on the opposite side of the joint, and causes them to undergo
a “passive” quick stretch, which potentially could elicit upper motor neuron signs. “Hyperactive
stretch reflexes may be elicited easily in an antagonistic spastic muscle and thus impede the
initiation or execution of agonist movement” (Nielson et al, 2006). However although we did not
measure spasticity during the intervention, via observation or participant report, spasticity was
not an apparent symptom in most participants. Any UMN signs that were observed were during
the 90 seconds in between sets and did not interrupt the completion of the protocol. Instances of
clonus were detected during two separate sessions, and LE extensor spasms were regularly noted
between sets in one participant however, the spasms faded within 90 seconds until the next set
and did not seem to affect his ability to complete the program. Although triggers of spasticity
include excess heat, fatigue, pain, or physical and/or emotional stress, it appears that voluntary
maximal effort utilized in MST does not elicit spasticity and may compete with it, by distracting
the nervous system, so to speak. (Phadke, Balasubramanian, Ismail, & Boulias, 2013) If this is
so, this may help explain the significant increases in strength, and limited symptoms of
spasticity. It may also be that the reorganized CNS that occurred due to increased neural drive
resulted in plastic CNS changes that limited the expression of UMN signs. Outside of the
incidents of spasticity mentioned above, no other upper motor neuron lesion signs were apparent
however, this is something that should be examined in future studies.
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LIMITATIONS TO MST STUDY
Our study is subject to a number of limitations. The present study was a pilot study with a
sample size of only seven subjects. Initially, one of the original 8 participants dropped out of the
study due to unrelated reasons. Second, one of the remaining seven participants completed only 7
out of the 8 weeks of the MST protocol due to scheduling complications. It is noted that due to
the small sample size, it is difficult to generalize the results found in the study across the MS
population. However, due to the unpredictable and variable presentation of the disease,
increasing sample size alone may not necessarily improve the generalizability of the research.
Since there is no stereotypical presentation of PwMS, other variables must be taken into
consideration that may help generalize these results. Specifically, although the sample size was
small, the variability in demographics in terms of EDSS score, age, clinical presentation and
years since diagnosis may have helped offset the smaller sample size.
Selection bias was another limitation due to the convenience sample that was used as all
subjects were former patients and/or subjects of the research advisor and have participated in
prior research concerning MS. As convenience samples are inherently non-randomized, it is
unlikely that the sample was representative of the entire studied population. Furthermore, prior
knowledge of MS-related research and relationship with the research advisor may have
contributed to biasing subjective measurements such as the VAFS and FSS, which were used to
quantify fatigue. Despite the inherent pitfalls that may be associated with a convenience sample,
due to the time constraints and limited financial resources, this method of sampling seemed to
the best alternative for the study.
In PwMS, fatigue is divided into MS-related fatigue and exercise-induced fatigue. Braley et
al. (2010) stated that the most commonly proposed contributors to MS-related fatigue are
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associated with the immune system and the central nervous system. Specifically, the influence of
proinflammatory cytokines, hormonal imbalances, axonal demyelination and degeneration, and
altered patterns of cerebral activation are thought to contribute to MS-related fatigue. As
discussed above, the VAFS and FSS, which are subjective measures, were used to quantify
fatigue - an objective phenomenon. Due to the unpredictable nature of the disease and the
subjective outcome measures utilized, it was difficult to differentiate whether the VAFS and FSS
measurements depicted increases in MS fatigue or exercise-induced fatigue.
Another limitation of the study is that outdoor temperature and humidity cannot be
controlled. As elevated temperatures and humidity have negative effects on persons with MS,
data collection was not performed during the summer months. However, despite conducting
experimental sessions outside summer months, there was still variability in weather conditions
such as precipitation and extreme cold that may have affected the patients’ fatigue levels prior to
sessions. To offset the variability of the outside temperatures, subjects were given 10-minute rest
periods prior to the beginning of each session; furthermore, objective measures were taken in
indoor hallways and all leg press protocols were completed in the same gym where temperature
was controlled. Variability in time of day subjects performed protocol was also a limitation. As
researchers and subjects had to accommodate respective schedules, the time of day for all
subjects were not standardized as some subjects were only available in the evenings (after having
worked an entire day) and others preferred mornings/early afternoons.
One of the outcome measures utilized for the study was the BBS, which is a clinically
accepted tool of quantifying balance in association with risk of falls. However, the BBS
inherently has a floor / ceiling effect that makes it a limitation. Specifically, a 56/56 on the BBS
does not indicate that the subject has a zero falls risk. Downs, Marquez, & Chiarelli (2013),
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noted that the floor or ceiling effects occur when the majority of the subjects score close to zero
or perfect on the test, which make it difficult to detect whether the change in balance was due to
the experimental intervention. For example, in the study, one patient had nearly a perfect score
during pre-testing. In persons with extremely good balance where most of the items are scored
4/4, the scale is unlikely to detect a change in balance even if there was one (Downs et al., 2013).
Another limitation was in determining 1RM. Although there was a standardized protocol in
obtaining a subject’s 1RM, there was a great deal of individual variability in obtaining this
outcome measure. Obtaining each subject’s 1RM required that the subjects start at an arbitrary
weight and incrementally (anywhere from 5 lbs up to 50 lbs) increase to the weight until only
one repetition can be performed with maximal effort. As subjects had varying levels of strength,
the increments that were increased were based upon clinical judgment, patient’s feedback, and
successful completion of the leg press. Attempts to obtain a 1RM during both pre and post-test
measures also varied. The number of attempts exceeded 10 times and unfortunately, with so
many attempts, one must consider the onset of exercise induced fatigue, especially in PwMS.
The challenge was determining how to minimize the number of attempts, which would require
greater weight increases. Using a dynamometer to assess force output may be worthy of
considering not only because it will decrease chances of fatigue but also because voluntary
activation during maximal dynamic contractions has been shown to be significantly lower than
voluntary activation during isometric contractions (Cormie et al. 2011).
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FUTURE RESEARCH
Future research should first address the aforementioned limitations. Specifically, a larger,
randomized sample size would be more generalizable and representative of the MS population.
Furthermore, the present study looked at impairment (reduced strength) and utilized the MST
protocol to hypothesize that an increase in strength measured by 1RM would translate into
improved gait and balance. This study provided potential mechanisms for the improvements in
strength, as well as the functional measures of gait and balance, but these are still only inferences
based on the current literature and the study’s findings. By further investigating the possible
causes of the results found in this study in these different domains, clinicians will be able to
better prescribe exercise that focus on the goal of the individuals. As mentioned, the study did
not include any task specific measures, suggesting that having strong antigravity muscles such as
hip and knee extensors play a significant role in performing static and dynamic tasks. Future
research should look at MST’s effect on task-specific outcome measures such as stair climbing,
as done by Symons, Vandervoot, Rice, Overend, & Marsh (2005) to further quantify MST’s
effect on function.
Future research should also include a measure of balance without a ceiling effect as this was
one limitation of the study. The ceiling effect limits the ability to objectively measure balance
improvements in subjects who had pretest scores of close to 56. A possible alternative would be
to incorporate the Mini-BESTest balance test as it not only minimizes the ceiling effect found in
the BBS but also incorporates aspects of the Timed Up and Go (TUG), Dynamic Gait Index
(DGI), and the BBS. King, Priest, Salarian, Pierce, & Horak (2012) looked at the effectiveness of
the Mini-BESTest versus the BBS specifically in persons with Parkinson’s Disease (PD). As in
PD, postural instability and balance deficits are significant impairments in persons with MS.
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King et al., (2012) noted that the high sensitivity of the Mini-BESTest is especially valuable as it
does a better job at picking up mild deficits in balance compared to the BBS; thus providing
neuromuscular intervention strategies earlier on in the disease progression.
Applying an outcome measure for upper motor neuron signs is suggested. In order to see
whether there is a statistically significant correlation between the MST protocol and increased
upper motor signs such as spasticity, an outcome measure may include the Modified Ashworth
Scale (MAS), as applied by Jayaraman, Thompson, Rymer, & Hornby (2013) in their study of
the effect of MST on persons with incomplete spinal cord injuries.
Other outcome measures to take into account are gait characteristics by quantitative gait
analysis. Temporal-spatial parameters such as stride length, step length, cadence and kinematic
parameters such as joint angles can be measured physically before and after an MST protocol to
determine improvement in function (Cerny, 1983). As a proper gait pattern with improved gait
mechanics would translate into increased efficiency and thus, decreased motor/exercise-induced
fatigue, quantitative gait analysis should be implemented in future research.
The method used in determining 1RM may have been a limitation in this study due to the
large amount of individual variability in number of attempts to reach 1RM. This may be
addressed by utilizing an isokinetic dynamometer to measure force output. This would allow for
a standardized number of attempts for maximal volitional contraction of the tested muscle(s) in
order to then correlate it with changes in force output after a strengthening protocol has been
implemented.
Finally, the MST intervention may also be utilized in future protocols isolating muscle
groups that are important during gait such as the hamstrings, gluteus medius, gluteus maximus
and gastroc/soleus complex, as these muscle groups are essential to gait and balance.
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Strengthening these specific muscle groups in isolation may translate into larger improvements
in balance and gait measures, which will undoubtedly change/add to the approach in
rehabilitation of PwMS.
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CONCLUSION
Despite the aforementioned limitations, this study provides evidence that MST in PwMS
resulted in statistically significant improvements in their 1RM, 6MWT times, and BBS scores.
These positive findings were associated with no significant changes in fatigue, which supports
the use of MST in the clinical setting for PwMS. It is important to note that with appropriate
supervision and proper body mechanics utilizing the leg press-machine, the MST protocol
implemented was safe. Although all the subjects in this study reported feeling better and stronger
after each session, further research should be conducted to specifically look at the link between
MST and psychological impact in persons with MS. Future studies will need to implement MST
with an increased sample size looking at balance measures with less ceiling effects, quantitative
gait analysis, maximal-contraction force outputs, and/or isolating the MST protocol to key
muscle groups important in function.
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APPENDIX

APPENDIX A: TYPES OF MULTIPLE SCLEROSIS
(Taken verbatim from The National Multiple Sclerosis Society)
Relapsing-remitting MS (RRMS)
RRMS — the most common disease course — is characterized by clearly defined attacks of
worsening neurologic function. These attacks — also called relapses, flare-ups or
exacerbations — are followed by partial or complete recovery periods (remissions), during
which symptoms improve partially or completely and there is no apparent progression of
disease. Approximately 85 percent of people with MS are initially diagnosed with relapsingremitting MS.
Secondary-progressive MS (SPMS)
The name for this course comes from the fact that it follows after the relapsing-remitting
course. Most people who are initially diagnosed with RRMS will eventually transition to
SPMS, which means that the disease will begin to progress more steadily (although not
necessarily more quickly), with or without relapses.
Primary-progressive MS (PPMS)
PPMS is characterized by steadily worsening neurologic function from the beginning.
Although the rate of progression may vary over time with occasional plateaus and
temporary, minor improvements, there are no distinct relapses or remissions. About 10
percent of people with MS are diagnosed with PPMS.
Progressive-relapsing MS (PRMS)
PRMS — the least common of the four disease courses — is characterized by steadily
progressing disease from the beginning and occasional exacerbations along the way. People
with this form of MS may or may not experience some recovery following these attacks; the
disease continues to progress without remissions.
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APPENDIX B: CONSENT TO PARTICIPATE AS A RESEARCH SUBJECT
Hunter College
Program in Physical Therapy
City University of New York
Consent to Participate as a Research Subject
Investigators:
Janet Dworetsky, SPT
David Park, SPT
Charlie Wright, SPT
Michael Zervas, SPT
Faculty Advisor:
Herbert I. Karpatkin, PT, DSc., NCS, MSCS, Associate Professor at Hunter College
Hunter College, Program in Physical Therapy
425 East 25th Street, N.Y., N.Y. 10010
212-481-5051
Purpose and Background
You are invited to participate in a research study. The study is conducted under the direction of
Dr. Herbert Karpatkin, PT D.Sc., associate professor at Hunter College in the Physical Therapy
Department. Janet Dworetsky, David Park, Charlie Wright, and Michael Zervas are doctoral
students in the Physical Therapy Program at Hunter College. The purpose of this research study
is to examine the effects of maximal strength training (MST) on gait and balance in persons with
multiple sclerosis (MS). You are being asked to participate in a study that will help determine if
MST is an effective exercise program for treating symptoms in MS patients. You were selected
for participation because you are a person with MS over 18 years of age, walks as a regular
means of transportation, and can perform exercises using a horizontal leg press machine. There
will be an anticipated 30 subjects that will participate in this study. Your participation in this
study is voluntary. You may choose to withdraw from the study at any time.
Procedures
Patients will perform testing individually. You will perform four sets of four repetitions on a
horizontal leg press machine at 85-95% of your one repetition maximum (1RM). The study will
take place at the Physical Therapy Department at Hunter College, 425 East 25th Street, N.Y,
N.Y., 10010, over the course of an 8 week period. Each session will last approximately 45
minutes, and will take place two days a week over the course of 8 weeks.
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The study procedures in detail are as follows:

















If you agree to be a subject, you will complete a questionnaire with the researchers to determine
if you are eligible for the study. The screening will ask questions about your medical history
including length of time with MS, medications, use of assistive devices for walking such as
canes, walkers, or splints, and whether you have a history of non-MS complications such as a
heart condition or orthopedic problems. The researchers will also look at information from your
medical records such as your Expanded Disability Status Scale Score (EDSS).
If your responses indicate that you are eligible, you will be asked to participate in this study. If
you are not eligible to participate, the information obtained from you during screening will be
omitted from this study and shredded to protect your privacy.
Once identified as an eligible subject, you will be asked to schedule a time to meet with Dr.
Karpatkin and two to four of the collaborating physical therapy students.
At that scheduled time, you will come to the Physical Therapy Department at Hunter College.
During the first visit, you will participate in the 6 minute walk test (6MWT), and Berg Balance
Scale (BBS) test, prior to beginning the MST program. These tests will be repeated at the end of
the 8 week period.
On the same day you will also be familiarized with the horizontal leg press machine at a very
low weight until comfortable, at which point the poundage will be increased to a level you feel is
about 50-75% of your maximum capacity. Single repetitions will be performed with increasing
weight (5-10 lbs) until only 1 repetition can be completed. This single repetition will be
determined as your 1RM.
A warm-up will be performed during each session, and will consist of either 5 minutes on a
treadmill or cycle ergometer. Following this, you will perform 5 repetitions at 50% of your 1RM.
This will conclude the warm-up.
The MST exercise protocol will consist of 4 sets of 4 repetitions at 85-95% of your 1RM per
visit. Once you are able to do more than 4 repetitions in a single set, the weight will increase by
5-10 lbs, with your feeling of capability guiding the exact weight increase.
After each set, you will take at least a 90 seconds rests prior to starting the next set.
A cool-down of 5 minutes will be performed on either a treadmill or cycle ergometer, concluding
the session.
The total time expected for each session is approximately 45 minutes, with the first and last
session taking longer due to the inclusion of the 6MWT and BBS tests.

None of the procedures or questionnaires in this study is experimental. The only experimental
aspect of this study is the gathering of information for the purpose of analysis.

Risks and/or Discomfort
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There are minimal risks to you from participation in this study. You may experience some
fatigue-related discomfort and delayed onset muscle soreness as a result of the exercise protocol.
Because fatigue is the most common symptom in persons with MS, it is important to note that
any fatigue experienced may be characteristic of the disease itself, as opposed to a result of the
testing conditions. The soreness the results in the days following exercising is normal and to be
expected. You will have at least 24 hours rest in between exercise sessions. The strength training
protocol of this study is not expected to worsen your fatigue, or any other aspect of your MS in
any way. Dr. Karpatkin will be beside you for the entire exercise duration, including the 6MWT
and BBS tests. Despite these safeguards, there is a chance that you could incur an orthopedic
injury from the horizontal leg press machine or that you may fall and sustain an injury at the
facility. If this should occur we will immediately contact your primary care physician and if
necessary take you to the emergency room.
If you are feeling bothered or upset as a result of participation, or for any reason wish to not
continue you may simply ask to stop and we will immediately end the procedure. You will be
free not to answer any item in any of the questionnaires or forms.
Benefits
There may be no direct benefits to you as an individual. This may increase your gait and balance
levels, and how they may vary based on different exercise protocols.
Voluntary Participation: Your participation in this study is voluntary, and you may decide not
to participate without prejudice, penalty, or loss of benefits to which you are otherwise entitled.
If you decide to leave the study, please contact the research coordinator, Dr. Karpatkin, to inform
him of your decision.
Alternatives
The alternative to this study is nonparticipation without repercussions or penalties.
Financial Considerations
Other than the cost of travel to and from the Physical Therapy Department at Hunter College,
there are no costs incurred by you for participation in the study.
Confidentiality
The data will be collected using the two fatigue surveys that you fill out, measuring the distance
walked within the three trials, and the change in 1RM. Strict confidentiality will be maintained.
Knowledge of your identity and participation in this study will be limited to Dr. Karpatkin, the
collaborating physical therapy students, and IRB members and staff. Information about your
participation will only be disclosed in the event of an emergency requiring hospitalization, and in
such a case will be disclosed to the treating hospital physician and your primary care physician.
53

Under expected non-emergency circumstances, no individual identifying information about you
will be disclosed. Where possible, all identifying references about you will be removed and
replaced by a numeric code. Participation in this research is voluntary and involves minimal loss
of your privacy. All questionnaires and data about you that will be used in computer analyses
will have number codes rather than your name. Your name will not be recorded on the
information or reported in any scientific paper or professional meeting to protect your identity.
All data will be reported in aggregate (group) fashion at a professional meeting or in a scientific
journal so that no one can identify any information about you. If data are used for a publication
in the medical literature or for teaching purposes, no names will be used. A master list of code
numbers as well as all other data pertaining to you and other subjects will be kept confidential by
the researchers and will be stored in a locked file cabinet in the faculty research advisor’s office.
Data that will be used for computer analyses will be kept on a flash drive and only researchers
involved in this study and representatives of the IRB members and staff will have access to the
records and information about this study. All original hardcopy data will be shredded seven years
after completion of the study. The code key connecting names to numbers will be kept in the
research office of Dr. Karpatkin. Confidentiality will be maintained to the extent allowed by law.
Withdrawal
You may terminate your participation from this study prior to the start or at any time during the
study without penalty, repercussion, or loss of compensation.
Contact Information
If you have questions about the study, you can contact Dr. Karpatkin, at 212-396-7115. You
should contact the Hunter College Human Research Protection Program (HRPP) Office at (212)
650-3053, if you have questions regarding your rights as a subject or if you feel you have been
harmed as a result of your participation in this research.
Signatures
I have read (or have had read to me) the contents of this consent forms and have been
encouraged to ask questions. I have received answers to my questions. I have received answers
to my questions. I give my consent to participate in this study. I have received (or will receive) a
copy of this form for my records and future references.

______________________
Participant’s Name

___________________________
Signature

___________
Date

_______________________
Researcher’s Name

___________________________
Signature

___________
Date
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APPENDIX C: SUBJECT DEMOGRAPHIC INFORMATION
Subject Demographic Information
Age: __________

Gender: M / F

Date of Birth: __________________

Type of Multiple Sclerosis: _______________________________________________________
Year since diagnosis of Multiple Sclerosis: __________________________________________
Expanded disability status scale (EDSS) Score: ____________________
Fatigue Severity Scale (FSS) Score: ____________________
Use of assistive device: __________________________________________________________
Use of anti-spasticity medications: _________________________________________________
Use of fatigue medication: _______________________________________________________

Questionnaire
1. Are you able to walk unassisted for 6 minutes with or without an assistive device?
YES

NO

2. Do you have any orthopedic, cardiovascular, or pulmonary issues that would be
compromised by talking or prohibit you from walking?
YES

NO

3. Are you able to read and comprehend an informed consent document?
YES

NO

4. Have you had evidence of an exacerbation in the past 4 weeks as determined by a
neurologist?
YES

NO

5. Have you received Methylprednisone treatment in the past 4 weeks?
YES

NO

6. Do you have difficulty following simple commands?
YES

NO
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APPENDIX D: FATIGUE SEVERITY SCALE (FSS)

Fatigue Severity Scale (FSS)
Your Name
Date:

Date of birth:

This questionnaire contains nine statements that rate the severity of your fatigue symptoms.
Read each statement and circle a number from 1 to 7, based on how accurately it reflects your
condition during the past week and the extent to which you agree or disagree that the statement
applies to you.
***A low value (e.g. 1) indicates strong disagreement with the statement, whereas a high value
(e.g. 7) indicates strong agreement.
During the past week, I have found that:

Disagree

Agree

1. My motivation is lower when I am fatigued

1 2 3 4 5 6 7

2. Exercise brings on my fatigue.

1 2 3 4 5 6 7

3. I am easily fatigued.

1 2 3 4 5 6 7

4. Fatigue interferes with my physical functioning.

1 2 3 4 5 6 7

5. Fatigue causes frequent problems for me.

1 2 3 4 5 6 7

6. My fatigue prevents sustained physical functioning.

1 2 3 4 5 6 7

7. Fatigue interferes with carrying out certain duties and responsibilities.

1 2 3 4 5 6 7

8. Fatigue is among my three most disabling symptoms.

1 2 3 4 5 6 7

9. Fatigue interferes with my work, family or social life.

1 2 3 4 5 6 7

Total Score:
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APPENDIX E: MULTIPLE SCLEROSIS IMPACT SCALE (MSIS-29)





Multiple Sclerosis Impact Scale (MSIS-29)
The following questions ask for your views about the impact of MS on your day-to-day life
during the past two weeks
For each statement, please circle the one number that best describes your situation
Please answer all questions

In the past two weeks, how much has
your MS limited your ability to...

Not at
all

A
little

Moderately Quite a Extremely
bit

1.

Do physically demanding tasks?

1

2

3

4

5

2.

Grip things tightly (e.g. turning on
taps)?
Carry things?

1

2

3

4

5

1

2

3

4

5

3.

In the past two weeks, how much have Not at
all
you been bothered by...

A
little

Moderately

Quite a
bit

Extremely

4.

Problems with your balance?

1

2

3

4

5

5.

1

2

3

4

5

6.

Difficulties moving about
indoors?
Being clumsy?

1

2

3

4

5

7.

Stiffness?

1

2

3

4

5

8.

Heavy arms and/or legs?

1

2

3

4

5

9.

Tremor of your arms or legs?

1

2

3

4

5

10.

Spasms in your limbs?

1

2

3

4

5

11.

Your body not doing what you
want it to do?
Having to depend on others to
do things for you?

1

2

3

4

5

1

2

3

4

5

12.

Please check that you have answered all the questions before going on to the next page
®2000 Neurological Outcome Measures Unit, 4th Floor Queen Mary Wing, NHNN,
Queen Square, London WC1N 3BG, UK
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APPENDIX F: DATA COLLECTION SHEETS

Pre and Post Test Results
Pre-Test Conditions

Scale(BBS)

Post-Test Conditions

Berg Balance
Six Minute Walk Test(6MWT) One Rep Maximum(1RM)

Subjects

Pre-Test

Post-Test

Pre-Test

Post-Test

Pre-Test

PostTest

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Comments:__________________________________________________

__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
__________________________________________________________
_________________________________________________________
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Weekly Test Results
Week #:_____
Day 1

Date: ____________
Temperature: _________
Humidity: __________

Warm up completed : Aerobic
Muscular
FSS Score:__________ (to be assessed at the beginning of each week)

VAFS_________

Least
Fatigue

Most
Fatigue

Weight used 1st set
Weight used 2nd set
Weight used 3rd set
Weight used 4th set

Repetitions completed
Repetitions completed
Repetitions completed
Repetitions completed

Cool down completed : Aerobic
Patient able to tolerate more weight?: Yes
Backrest setting:_______________

No

Day 2
Warm up completed : Aerobic

Date: ____________
Temperature: _________
Humidity: __________

Muscular

Least

Most
Fatigue

VAFS_________ Fatigue
Weight used 1st set
Weight used 2nd set
Weight used 3rd set
Weight used 4th set
Cool down completed : Aerobic
Patient able to tolerate more weight?: Yes
Backrest setting:_______________

Repetitions completed
Repetitions completed
Repetitions completed
Repetitions completed

No

Comments _____________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
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Pre Test Results
ITEM DESCRIPTION
Sitting to standing
Standing unsupported
Sitting unsupported
Standing to sitting
Transfers
Standing with eyes closed
Standing with feet together
Reaching forward with outstretched arm
Retrieving object from floor
Turning to look behind
Turning 360 degrees
Placing alternate foot on stool
Standing with one foot in front
Standing on one foot
Total
Post Test Results
ITEM DESCRIPTION
Sitting to standing
Standing unsupported
Sitting unsupported
Standing to sitting
Transfers
Standing with eyes closed
Standing with feet together
Reaching forward with outstretched arm
Retrieving object from floor
Turning to look behind
Turning 360 degrees
Placing alternate foot on stool
Standing with one foot in front
Standing on one foot
Total

SCORE (0-4)
________
________
________
________
________
________
________
________
________
________
________
________
________
________
________

SCORE (0-4)
________
________
________
________
________
________
________
________
________
________
________
________
________
________
________

Date: ____________
Temperature: _________
Humidity: __________

Date: ____________
Temperature: _________
Humidity: __________
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1 Repetition Maximum
Date: ____________
Temperature: _________
Humidity: __________

Pre Test Results
Least
Fatigue

Most
Fatigue

VASF

1st attempt

1 rep max:_________________

2nd attempt

85% 1 rep max:_____________

3rd attempt

90% 1 rep max:_____________

4th attempt

95% 1 rep max:_____________

5th attempt
6th attempt
Date: ____________
Temperature: _________
Humidity: __________

Post Test Results
Least
Fatigue

Most
Fatigue

VASF

1st attempt

1 rep max:______________

2nd attempt
3rd attempt
4th attempt
5th attempt
6th attempt
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6 Minute Walk Test
Date: ____________
Temperature: _________
Humidity: __________

Pre Test Results
Least
Fatigue

Most
Fatigue

VASF

Distance after 1”
Distance after 2”
Distance after 3”
Distance after 4”
Distance after 5”
Distance after 6”
Date: ____________
Temperature: _________
Humidity: __________

Post Test Results
Least
Fatigue

Most
Fatigue

VASF

Distance after 1”
Distance after 2”
Distance after 3”
Distance after 4”
Distance after 5”
Distance after 6”
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APPENDIX G: DATA TABLES

Subject
#

Year
Collected

Age

Gender
(M/F)

Yrs Since
Diagnosis

MS Diagnosis

EDSS

Assistive
Device

MSIS-29

1

2014

62

F

21

SPMS

6

Walker, Cane

81

2

2014

44

M

3

PPMS

3

Cane

92

4

2014

69

F

35

SPMS

3

5

2014

62

F

4

SPMS

3

None

Cane, AFO

54

Ampyra

FES

80

6

2014

34

M

5

RRMS

2.5

Baclofen

54

Ampyra

None
Walk Aide,
FES

7

2014

45

F

19

SPMS

3

8

2014

45

F

13

RRMS

4.5

Baclofen

Cane

80

Medications
Modafinil,
Ampyra
Tizanidine,
Ampyra,
Amatidine

43

Table 7: Subject Demographics & Characteristics
MS, Multiple Sclerosis; EDSS, Expanded Disability Status Scale; FSS, Fatigue Severity Scale; RR, relapsing-remitting;
SP, secondary progressive; PP, primary progressive; 6MWT, 6 Minute Walk Test

One Repetition Maximum (1RM) per Subject and Week (lbs)
Subject # 1
Week

Session Two
Left Leg
1
27.5
95
2
27.5
100
3
30
110
4
35
120
5
40
122.5
6
42.5
132.5
7
45
135
8
45
140
1RM Change
+50
Table 8: 1RM Weekly Changes in Weight (Subject #1); 1RM, 1 Repetition Maximum
Subject # 2
Week

Right Leg

Session One
Left Leg
90
95
105
115
122.5
127.5
132.5
137.5

Session Two
Left Leg
1
152.5
130
2
157.5
140
3
170
155
4
177.5
155
5
187.5
165
6
197.5
177.5
7
207.5
187.5
8
215
192.5
1RM Change
62.5
Table 9: 1RM Weekly Changes in Weight (Subject #2); 1RM, 1 Repetition Maximum
Right Leg

Session One
Left Leg
130
135
147.5
150
160
172.5
182.5
190

Right Leg

27.5
27.5
32.5
37.5
40
45
45
47.5
+20

Right Leg

152.5
162.5
177.5
182.5
192.5
202.5
217.5
217.5
65
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Subject # 4
Week

Session Two
Left Leg
1
112.5
55
2
122.5
55
3
122.5
57.5
4
127.5
57.5
5
132.5
62.5
6
132.5
62.5
7
132.5
62.5
8
135
65
1RM Change
+10
Table 10: 1RM Weekly Changes in Weight (Subject #4); 1RM, 1 Repetition Maximum
Subject # 5
Week

Right Leg

Session One
Left Leg
55
50
55
57.5
60
62.5
62.5
62.5

Session Two
Left Leg
1
72.5
80
2
80
90
3
85
95
4
95
NT
5
100
110
6
100
117.5
7
105
122.5
8
105
127.5
1RM Change
+52.5
Table 11: 1RM Weekly Changes in Weight (Subject #5); 1RM, 1 Repetition Maximum
Subject # 6
Week

Right Leg

Session One
Left Leg
75
85
90
100
105
115
120
125

Right Leg

Subject # 7
Week

Session One
Left Leg
292.5
297.5
302.5
305
310
312.5
317.5
320

Right Leg

Session Two
Left Leg
1
292.5
295
2
300
300
3
302.5
305
4
302.5
307.5
5
305
310
6
307.5
315
7
307.5
317.5
8
310
322.5
1RM Change
+30
Table 12: 1RM Weekly Changes in Weight (Subject #6); 1RM, 1 Repetition Maximum
Right Leg

Session One
Left Leg
85
95
97.5
102.5
110
115
120
130

75
82.5
90
NT
100
102.5
105
105
+32.5

Right Leg

Session Two
Left Leg
1
67.5
90
2
77.5
97.5
3
80
100
4
82.5
105
5
87.5
NT
6
92.5
120
7
100
125
8
105
135
1RM Change
+50
Table 13: 1RM Weekly Changes in Weight (Subject #7); 1RM, 1 Repetition Maximum
Right Leg

117.5
122.5
127.5
130
132.5
132.5
135
135
+22.5

295
302.5
302.5
302.5
305
307.5
307.5
310
+17.5

Right Leg

72.5
80
80
82.5
NT
97.5
102.5
110
+42.5
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Subject # 8
Week

Session Two
Left Leg
1
167
192.5
2
172.5
NT
3
175
205
4
182.5
212.5
5
190
217.5
6
197.4
225
7
202.5
227.5
8
NT
NT
1RM Change
+37.5
Table 14: 1RM Weekly Changes in Weight (Subject #8); 1RM, 1 Repetition Maximum
Right Leg

Session One
Left Leg
190
197.5
200
210
215
222.5
225
NT

Right Leg

167
NT
177.5
185
192.5
200
202.5
NT
+35
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Six Minute Walk Test (6MWT) Pre and Post Test

Subject
#
1
2
4

5
6

7
8

1
Min
103
103
138.1
138.1
174.8
174.8

Pre Test (ft)
2
3
Min Min 4 Min 5 Min 6 Min
204 303
383
463
553
101
99
80
80
90
273.7 398.3 513.1 624
732.1
135.6 124.6 114.8 110.9
108
351 530
705
888
1071
176.8 179
175
183
183

259
259
293.1
293.1

504.3
245.3
582.4
289.3

723.1 939.1 1159.9 *1389.3 279.5
218.8 216 220.8 229.4 279.5
866.9 1156.7 1465.8 *1733.1 355.9
284.5 289.8 309.1 267.3 355.9

207
207
113.8
113.8

404.9
197.9
240.4
126.6

597.1
192.2
357.8
117.4

782.8
185.7
472.1
114.3

Post Test (ft)
1 Min
93.6
93.6
146.6
146.6
187.2
187.2

2 Min
167.6
74
286.1
139.5
418
230.8

3 Min
244.7
77.1
421.9
135.8
616.1
198.1

6 Min
474.8
80.2
799.1
122.9
1188.4
184.1
*1680.
578.9 864 1154.6 1436.9 6
299.4 285.1 290.6 282.3 243.7
715 1066.3 1414 1757 *2103
359.1 351.3 347.7 343
346

974.6 1162.3 233.7 464.3 689
191.8 187.7 233.7 230.6 224.7
579.9 681.3 121.9 582.4 377.2
107.8 101.4 121.9 132.2 123.1

4 Min
309.9
65.2
532.4
110.5
816.1
200

5 Min
394.6
84.7
676.2
113.8
1004.3
188.2

912.1 1141.7 1373.6
223.1 229.6 231.9
496.6 622.4 742.1
119.4 125.8 119.7

Table 15: Cumulative (Top Row) and Incremental (Bottom Row) Pre & Post Test 6MWT; 6MWT, Six Minute Walk Test
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Weekly Subject Fatigue Severity Scale (FSS) Scores
Subject # Week 1
Week 2
Week 3
Week 4
Week 5
1
58
59
51
56
60
2
55
61
59
59
50
4
23
34
27
29
29
5
60
62
63
63
63
6
28
49
43
40
49
7
33
36
36
36
41
8
51
45
52
49
48
Table 16: Weekly FSS Scores (Individual Values); FSS, Fatigue Severity Scale

Week 6
62
51
32
63
48
42
53

Week 7
55
61
50
62
44
42
58

Week 8
57
60
30
63
49
44
N/A

Average FSS Scores
Subjects

FSS Average

1
2
4
5
6
7
8

57.25
57.0
29.25
62.38
43.75
38.75
50.86

Table 17: Average FSS Scores (Individual Values); FSS, Fatigue Severity Scale

Visual Analog Scale of Fatigue Scores (VASF) per Subject and Week (mm)
Subject #1
Week

Session One
VASF pre
VASF post
VASF change VASF pre
1
29.00
42.00
+13.00
21.00
2
64.00
78.00
+14.00
20.00
3
38.00
40.00
+2.00
61.00
4
31.00
33.00
+2.00
39.00
5
56.00
60.00
+4.00
44.00
6
50.00
54.00
+4.00
N/A
7
72.00
76.00
+4.00
46.00
8
47.00
55.00
+8.00
73.00
Table 18: VAFS Weekly Scores (Subject #1); VAFS, Visual Analog Fatigue Scale

Session Two
VASF post
30.00
21.00
63.00
48.00
47.00
N/A
58.00
83.00

VASF change
+9.00
+1.00
+2.00
+9.00
+3.00
N/A
+12.00
+10.00

Subject #2
Week

Session Two
VASF post
37.00
47.00
36.00
43.00
44.00
25.00
26.00
27.00

VASF change
+7.00
0.00
+4.00
+2.00
0.00
+5.00
0.00
0.00

Session One
VASF pre
VASF post
VASF change VASF pre
1
50.00
51.00
+1.00
30.00
2
28.00
29.00
+1.00
47.00
3
44.00
44.00
0.00
32.00
4
47.00
47.00
0.00
41.00
5
44.00
46.00
+2.00
44.00
6
42.00
46.00
+4.00
20.00
7
57.00
63.00
+5.00
26.00
8
38.00
35.00
-3.00
27.00
Table 19: VAFS Weekly Scores (Subject #2); VAFS, Visual Analog Fatigue Scale
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Subject #4
Week

Session One
VASF pre
VASF post
VASF change VASF pre
1
22.00
30.00
+8.00
29.00
2
34.00
47.00
+13.00
25.00
3
59.00
71.00
+12.00
24.00
4
12.00
22.00
+10.00
30.00
5
30.00
49.00
+19.00
33.00
6
49.00
58.00
+9.00
23.00
7
24.00
39.00
+15.00
34.00
8
56.00
64.00
+8.00
34.00
Table 20: VAFS Weekly Scores (Subject #4); VAFS, Visual Analog Fatigue Scale

Session Two
VASF post
42.00
47.00
34.00
36.00
41.00
33.00
41.00
54.00

VASF change
+13.00
+22.00
+10.00
+6.00
+8.00
+10.00
+7.00
+20.00

Subject #5
Week

Session Two
VASF post
54.00
55.00
48.00
NA
59.00
61.00
62.00
55.00

VASF change
-5.00
0.00
-6.00
NA
-9.00
-5.00
-5.00
-5.00

Session Two
VASF post
34.00
56.00
57.00
37.00
63.00
39.00
65.00
34.00

VASF change
+33.00
+52.00
+41.00
+26.00
+24.00
+24.00
+38.00
+25.00

Session Two
VASF post
24.00
16.00
17.00
22.00
NA
34.00
32.00
NA

VASF change
-1.00
-3.00
-2.00
0.00
NA
-2.00
-3.00
NA

Session Two
VASF post
29.00
NA
26.00
25.00
31.00
42.00
43.00

VASF change
-11.00
NA
-18.00
-15.00
-6.00
-7.00
-19.00

Session One
VASF pre
VASF post
VASF change VASF pre
1
62.00
56.00
-6.00
59.00
2
75.00
64.00
-11.00
55.00
3
63.00
53.00
-10.00
54.00
4
70.00
63.00
-7.00
NA
5
63.00
56.00
-7.00
68.00
6
62.00
55.00
-7.00
66.00
7
69.00
65.00
-4.00
67.00
8
63.00
59.00
-4.00
60.00
Table 21: VAFS Weekly Scores (Subject #5); VAFS, Visual Analog Fatigue Scale
Subject #6
Week

Session One
VASF post
VASF change VASF pre
1
2.00
20.00
+18.00
1.00
2
2.00
45.00
+43.00
4.00
3
13.00
44.00
+31.00
16.00
4
25.00
47.00
+22.00
11.00
5
7.00
35.00
+28.00
39.00
6
42.00
62.00
+20.00
15.00
7
26.00
56.00
+30.00
27.00
8
16.00
50.00
+34.00
9.00
Table 22: VAFS Weekly Scores (Subject #6); VAFS, Visual Analog Fatigue Scale
VASF pre

Subject #7
Week

Session One
VASF pre
VASF post
VASF change VASF pre
1
25.00
25.00
0.00
25.00
2
24.00
22.00
-2.00
19.00
3
51.00
49.00
-2.00
19.00
4
31.00
34.00
+3.00
22.00
5
45.00
41.00
-4.00
NA
6
51.00
49.00
-2.00
36.00
7
48.00
46.00
-2.00
35.00
8
NA
NA
NA
NA
Table 23: VAFS Weekly Scores (Subject #7); VAFS, Visual Analog Fatigue Scale
Subject #8
Week
1
2
3
4
5
6
7

VASF pre
41.00
35.00
44.00
30.00
NA
48.00
47.00

Session One
VASF post
26.00
24.00
30.00
-19.00
NA
29.00
32.00

VASF change
-15.00
-11.00
-14.00
-11.00
NA
-19.00
-15.00

VASF pre
40.00
NA
44.00
40.00
37.00
49.00
62.00
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Table 24: VAFS Weekly Scores (Subject #8); VAFS, Visual Analog Fatigue Scale

Visual Analog Scale of Fatigue Scores (VASF) Averages for Pre & Post Exercise & Change
Average Values
VASF post
VASF change
1
40.1
52.53
+6.47
2
38.56
40.38
+1.81
4
32.38
44.25
+11.88
5
63.73
57.67
-6.00
6
15.93
43.13
+30.56
7
33.15
32.00
-1.54
8
39.77
27.38
-12.38
Table 25: Pre & Post Test VAFS (Individual Changes); VAFS, Visual Analog Fatigue Scale
Subjects

VASF pre
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